Literature DB >> 18295436

Does initial treatment focus influence outcomes for depressed substance abusers?

Michelle L Drapkin1, Susan R Tate, John R McQuaid, Sandra A Brown.   

Abstract

Interventions for alcohol- and substance-dependent adults with comorbid depressive disorders are needed, but few have been empirically tested. In a randomized clinical trial of two psychotherapy interventions for these disorders, we examined whether initial focus of treatment was related to retention, substance use, and depression outcomes. Both interventions, integrated cognitive-behavioral therapy (ICBT; n = 105) and twelve-step facilitation (n = 92), were delivered in group formats with entry points every 4 weeks at the beginning of three content-distinct modules. Entry module (i.e., initial treatment focus) was not related to percentage days abstinent, proportion of the sample abstinent, or depression symptoms for either intervention. This was true at both 12 and 24 weeks postbaseline. Furthermore, attendance was similar for both treatments, regardless of initial treatment focus, with a single exception in the ICBT condition. Our findings support the use of modular formats with multiple or rotating entry points for psychotherapy group interventions.

Entities:  

Mesh:

Year:  2008        PMID: 18295436      PMCID: PMC3772784          DOI: 10.1016/j.jsat.2007.12.005

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  16 in total

1.  Future research directions and the impact of the MATCH project on research technology in the addictions.

Authors:  L San
Journal:  Addiction       Date:  1999-01       Impact factor: 6.526

2.  Does retention matter? Treatment duration and improvement in drug use.

Authors:  Zhiwei Zhang; Peter D Friedmann; Dean R Gerstein
Journal:  Addiction       Date:  2003-05       Impact factor: 6.526

3.  A component analysis of cognitive-behavioral treatment for depression.

Authors:  N S Jacobson; K S Dobson; P A Truax; M E Addis; K Koerner; J K Gollan; E Gortner; S E Prince
Journal:  J Consult Clin Psychol       Date:  1996-04

4.  Nonspecific improvement effects in depression using interpersonal skills training, pleasant activity schedules, or cognitive training.

Authors:  A M Zeiss; P M Lewinsohn; R F Muñoz
Journal:  J Consult Clin Psychol       Date:  1979-06

5.  Integrated cognitive behavioral therapy versus twelve-step facilitation therapy for substance-dependent adults with depressive disorders.

Authors:  Sandra A Brown; Suzette V Glasner-Edwards; Susan R Tate; John R McQuaid; John Chalekian; Eric Granholm
Journal:  J Psychoactive Drugs       Date:  2006-12

6.  A comparison of social-skills training, pharmacotherapy and psychotherapy for depression.

Authors:  A S Bellack; M Hersen; J M Himmelhoch
Journal:  Behav Res Ther       Date:  1983

7.  Comparison of alcoholics' self-reports of drinking behavior with reports of collateral informants.

Authors:  S A Maisto; L C Sobell; M B Sobell
Journal:  J Consult Clin Psychol       Date:  1979-02

8.  The Composite International Diagnostic Interview. An epidemiologic Instrument suitable for use in conjunction with different diagnostic systems and in different cultures.

Authors:  L N Robins; J Wing; H U Wittchen; J E Helzer; T F Babor; J Burke; A Farmer; A Jablenski; R Pickens; D A Regier
Journal:  Arch Gen Psychiatry       Date:  1988-12

9.  The role of functional social support in treatment retention and outcomes among outpatient adult substance abusers.

Authors:  Patricia L Dobkin; Civita Mirella De; Antonios Paraherakis; Kathryn Gill
Journal:  Addiction       Date:  2002-03       Impact factor: 6.526

10.  Measurement of depression in alcoholics.

Authors:  M L Willenbring
Journal:  J Stud Alcohol       Date:  1986-09
View more
  9 in total

1.  Bayesian restricted spatial regression for examining session features and patient outcomes in open-enrollment group therapy studies.

Authors:  Susan M Paddock; Thomas J Leininger; Sarah B Hunter
Journal:  Stat Med       Date:  2015-08-13       Impact factor: 2.373

2.  Does group cognitive-behavioral therapy module type moderate depression symptom changes in substance abuse treatment clients?

Authors:  Susan M Paddock; Sarah B Hunter; Thomas J Leininger
Journal:  J Subst Abuse Treat       Date:  2014-03-01

3.  Predictors of suicide-related hospitalization among U.S. veterans receiving treatment for comorbid depression and substance dependence: who is the riskiest of the risky?

Authors:  Jennifer Mrnak-Meyer; Susan R Tate; Jessica C Tripp; Matthew J Worley; Archana Jajodia; John R McQuaid
Journal:  Suicide Life Threat Behav       Date:  2011-08-04

4.  Predictors of treatment retention for substance-dependent adults with co-occurring depression.

Authors:  Susan R Tate; Jennifer Mrnak-Meyer; Chris L Shriver; Joseph H Atkinson; Shannon K Robinson; Sandra A Brown
Journal:  Am J Addict       Date:  2011-05-31

5.  An effectiveness trial of group cognitive behavioral therapy for patients with persistent depressive symptoms in substance abuse treatment.

Authors:  Katherine E Watkins; Sarah B Hunter; Kimberly A Hepner; Susan M Paddock; Erin de la Cruz; Annie J Zhou; Jim Gilmore
Journal:  Arch Gen Psychiatry       Date:  2011-06

6.  Clinical outcomes of an integrated treatment for depression and substance use disorders.

Authors:  Katherine P Lydecker; Susan R Tate; Kevin M Cummins; John McQuaid; Eric Granholm; Sandra A Brown
Journal:  Psychol Addict Behav       Date:  2010-09

Review 7.  Treatment of the depressed alcoholic patient.

Authors:  Jeffrey J DeVido; Roger D Weiss
Journal:  Curr Psychiatry Rep       Date:  2012-12       Impact factor: 5.285

8.  Impact of Physical Health on Treatment for Co-occurring Depression and Substance Dependence.

Authors:  Jessica C Tripp; Jessica R Skidmore; Ruifeng Cui; Susan R Tate
Journal:  J Dual Diagn       Date:  2013

9.  Treatment Attendance Among Veterans With Depression, Substance Use Disorder, and Trauma.

Authors:  Ruifeng Cui; Moira Haller; Jessica R Skidmore; Kelly Goldsteinholm; Sonya Norman; Susan R Tate
Journal:  J Dual Diagn       Date:  2016
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.